RR
Rama Rao Damerla
About Rama Rao Damerla
Data last updated:
Rama Rao Damerla has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Drava Life Sciences Private Limited and Euclase Genetics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Drava Life Sciences Private Limited at ₹3.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Nov 2020 | 2020 | ₹3.1 Lakh (FY 2025) | Active | |
| Director | 04 Jun 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rama Rao Damerla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rama Rao Damerla
Rama Rao Damerla has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Drava Life Sciences Private Limited and Euclase Genetics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Drava Life Sciences Private Limited at ₹3.1 Lakh (FY 2025).
Rama Rao Damerla is associated with 2 companies as Director, including Drava Life Sciences Private Limited (₹3.1 Lakh), Euclase Genetics Private Limited.
Rama Rao Damerla has expertise in General Business.
Rama Rao Damerla has 5 years in corporate governance.
By reported revenue, the largest current company of Rama Rao Damerla is Drava Life Sciences Private Limited, with revenue of ₹3.1 Lakh (FY 2025).
Rama Rao Damerla currently holds positions at 2 companies: Drava Life Sciences Private Limited (₹3.1 Lakh), Euclase Genetics Private Limited.